Plant asparaginase versus microbial asparaginase as anticancer agent
- PMID: 34978032
- DOI: 10.1007/s11356-021-17925-1
Plant asparaginase versus microbial asparaginase as anticancer agent
Abstract
The considerable effect of enzymes on human health draws great attention to enzyme-based drugs (therapeutic enzymes), in recent times. L-asparaginase (ASNase) is a well-known therapeutic enzyme. It has varied applications and is a single molecule for the treatment of multiple diseases. This study tries to extract asparaginase from soybean debris (agricultural wastes) as a cheap plant source and compare this with microbial asparaginase as an agent in cancer chemotherapy. The asparaginase was extracted and purified from soybean debris (plant asparaginase) and Pseudomonas aeruginosa (microbial asparaginase), then the physiochemical characters were determined for the two enzymes, and the anticancer activity of plant and microbial asparaginase was determined against gastric cancer (CLS-145), pancreatic cancer (AsPC-1), colon cancer (HCT116), esophagus cancer (KYSE-410), liver cancer (HepG2), breast cancer (MCF-7), and cervical cancer (HELLA). The results showed that plant asparaginase was superior to microbial asparaginase in its physiochemical characters. Plant asparaginase showed higher stability and activity under the conditions of changing either the temperature or the pH; also plant asparaginase has a higher affinity to the asparagine than the microbial asparaginase; besides, this plant asparaginase did not show activity with glutamine as a substrate. The plant asparaginase showed higher anticancer activity than that of microbial asparaginase against all studied cancer cell lines. The present study introduces as the first time a comparative study between the plant and microbial asparaginase which proves that soybean debris asparaginase can be more efficient and safe than that of the microbial asparaginase as an anticancer agent.
Keywords: Anticancer activity; Pseudomonas aeruginosa; Soybean debris; Thermal stability; pH stability.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
L-asparaginase from the novel Fusarium falciforme AUMC 16563: extraction, purification, characterization, and cytotoxic effects on PC-3, HePG-2, HCT-116, and MCF-7 cell lines.BMC Microbiol. 2025 Mar 17;25(1):145. doi: 10.1186/s12866-025-03833-8. BMC Microbiol. 2025. PMID: 40091012 Free PMC article.
-
Production and Anticancer Activity of an L-Asparaginase from Bacillus licheniformis Isolated from the Red Sea, Saudi Arabia.Sci Rep. 2019 Mar 6;9(1):3756. doi: 10.1038/s41598-019-40512-x. Sci Rep. 2019. PMID: 30842557 Free PMC article.
-
Therapeutic l-asparaginase: upstream, downstream and beyond.Crit Rev Biotechnol. 2017 Feb;37(1):82-99. doi: 10.3109/07388551.2015.1120705. Epub 2015 Dec 23. Crit Rev Biotechnol. 2017. PMID: 26694875 Review.
-
Characterization and applications of glutaminase free L-asparaginase from indigenous Bacillus halotolerans ASN9.PLoS One. 2023 Nov 28;18(11):e0288620. doi: 10.1371/journal.pone.0288620. eCollection 2023. PLoS One. 2023. PMID: 38015853 Free PMC article.
-
Bacterial l-asparaginases for cancer therapy: Current knowledge and future perspectives.J Cell Physiol. 2019 Nov;234(11):19271-19279. doi: 10.1002/jcp.28563. Epub 2019 Apr 16. J Cell Physiol. 2019. PMID: 30993718 Review.
Cited by
-
Engineering and Expression Strategies for Optimization of L-Asparaginase Development and Production.Int J Mol Sci. 2023 Oct 16;24(20):15220. doi: 10.3390/ijms242015220. Int J Mol Sci. 2023. PMID: 37894901 Free PMC article. Review.
-
Targeted Polymeric Micelles System, Designed to Carry a Combined Cargo of L-Asparaginase and Doxorubicin, Shows Vast Improvement in Cytotoxic Efficacy.Polymers (Basel). 2024 Jul 26;16(15):2132. doi: 10.3390/polym16152132. Polymers (Basel). 2024. PMID: 39125158 Free PMC article.
-
Agricultural wastes: a new promising source for phenylalanine ammonia-lyase as anticancer agent.3 Biotech. 2024 Jan;14(1):22. doi: 10.1007/s13205-023-03871-x. Epub 2023 Dec 26. 3 Biotech. 2024. PMID: 38156037 Free PMC article.
-
A Novel Approach for the Activity Assessment of L-Asparaginase Formulations When Dealing with Complex Biological Samples.Int J Mol Sci. 2025 May 29;26(11):5227. doi: 10.3390/ijms26115227. Int J Mol Sci. 2025. PMID: 40508036 Free PMC article.
-
Enzyme Engineering Strategies for the Bioenhancement of L-Asparaginase Used as a Biopharmaceutical.BioDrugs. 2023 Nov;37(6):793-811. doi: 10.1007/s40259-023-00622-5. Epub 2023 Sep 12. BioDrugs. 2023. PMID: 37698749 Review.
References
-
- Adeola HA, Bano A, Vats R, Vashishtha A, Verma D, Kaushik D, Mittal V, Rahman MDH, Najda A, Albadrani GM, Sayed AA, Farouk SM, Hassanein EHM, Akhtar MF, Saleem A, Abdel-Daim MM, Bhardwaj R (2021) Bioactive compounds and their libraries: an insight into prospective phytotherapeutics approach for oral mucocutaneous cancers. Biom Pharmacother 141:111809. https://doi.org/10.1016/j.biopha.2021.111809 - DOI
-
- Al Yousef SA (2021) Fusarium sp. L-asparaginases: purification, characterization, and potential assessment as an antileukemic chemotherapeutic agent. Environ Sci Pollut Res. https://doi.org/10.1007/s11356-021-16175-5 - DOI
-
- Arumugam N, Thangavelu P (2022) Purification and anticancer activity of glutaminase and urease free intracellular l-asparaginase from Chaetomium sp. Protein Expr Purif 190:106006. https://doi.org/10.1016/j.pep.2021.106006 - DOI
-
- Ashok A, Doriya K, Rao JV, Qureshi A, Tiwari AK, Kumar DS (2019) Microbes producing L-asparaginase free of glutaminase and urease isolated from extreme locations of Antarctic soil and moss. Sci Rep 9:1423. https://doi.org/10.1038/s41598-018-38094-1 - DOI
-
- Beckett A, Gervais D (2019) What makes a good new therapeutic L-asparaginase? World J Microbiol Biotechnol 35:152. https://doi.org/10.1007/s11274-019-2731-9 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources